Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun 1;225(11):1871-1875.
doi: 10.1093/infdis/jiac046.

Antimicrobial Susceptibility Survey of Invasive Neisseria meningitidis, United States 2012-2016

Caelin C Potts  1 , Lorraine D Rodriguez-Rivera  2   3 , Adam C Retchless  1 , Fang Hu  3 , Henju Marjuki  1 , Amy E Blain  1 , Lucy A McNamara  1 , Xin Wang  1
Affiliations

Antimicrobial Susceptibility Survey of Invasive Neisseria meningitidis, United States 2012-2016

Caelin C Potts et al. J Infect Dis. .

Abstract

Background: Historically, antimicrobial resistance has been rare in US invasive meningococcal disease cases.

Methods: Meningococcal isolates (n = 695) were collected through population-based surveillance, 2012-2016, and national surveillance, 2015-2016. Antimicrobial susceptibility was assessed by broth microdilution. Resistance mechanisms were characterized using whole-genome sequencing.

Results: All isolates were susceptible to 6 antibiotics (cefotaxime, ceftriaxone, meropenem, rifampin, minocycline, and azithromycin). Approximately 25% were penicillin or ampicillin intermediate; among these, 79% contained mosaic penA gene mutations. Less than 1% of isolates were penicillin, ampicillin, ciprofloxacin, or levofloxacin resistant.

Conclusions: Penicillin- and ampicillin-intermediate isolates were common, but resistance to clinically relevant antibiotics remained rare.

Keywords: Neisseria meningitidis; penA; antibiotic resistance; antimicrobial susceptibility; ciprofloxacin; invasive meningococcal disease; penicillin.

PubMed Disclaimer

Conflict of interest statement

Potential conflicts of interest. All authors: No reported conflicts of interest. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.

Comment in

References

    1. Potts CC, Joseph SJ, Chang HY, et al. Population structure of invasive Neisseria meningitidis in the United States, 2011–15. J Infect 2018; 77:427–34. - PMC - PubMed
    1. American Academy of Pediatrics Committee on Infectious Disease, Kimberlin DW, Barnett ED, Lynfield R, Sawyer MH. Red Book: 2021 Report of the Committee on Infectious Diseases. 32nd ed. Red Book® Online; 2021.
    1. McNamara LA, Potts C, Blain AE, et al. Detection of ciprofloxacin-resistant, β-lactamase-producing Neisseria meningitidis serogroup Y isolates—United States, 2019–2020. MMWR Morb Mortal Wkly Rep 2020; 69:735–9. - PMC - PubMed
    1. McNamara LA, Topaz N, Wang X, Hariri S, Fox L, MacNeil JR. High risk for invasive meningococcal disease among patients receiving eculizumab (Soliris) despite receipt of meningococcal vaccine. MMWR Morb Mortal Wkly Rep 2017; 66:734–7. - PMC - PubMed
    1. Potts CC, Retchless AC, McNamara LA, et al. Acquisition of ciprofloxacin resistance among an expanding clade of β-lactamase-positive, serogroup Y Neisseria meningitidis in the United States. Clin Infect Dis 2021; 73:1185–93 - PMC - PubMed

Publication types

MeSH terms